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Construction of a chemical system capable of replication
and evolution, fed only by small molecule nutrients, is now
conceivable.Thiscouldbeachievedbystepwiseintegration
of decades of work on the reconstitution of DNA, RNA and
protein syntheses from pure components. Such a minimal
cell project would initially deﬁne the components sufﬁcient
for each subsystem, allow detailed kinetic analyses and
lead to improved in vitro methods for synthesis of
biopolymers, therapeutics and biosensors. Completion
would yield a functionally and structurally understood
self-replicating biosystem. Safety concerns forsynthetic life
will be alleviated by extreme dependence on elaborate
laboratory reagents and conditions for viability. Our
proposed minimal genome is 113kbp long and contains
151 genes. We detail building blocks already in place and
major hurdles to overcome for completion.
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Overview
‘How far can we push chemical self-assembly?’
Thisquestionwasposedrecentlyasoneofthebig25questions
in science for the next 25 years (Service, 2005). Nowadays, big
questions often are addressed by big experimental efforts. But
before embarking on a big project, it is helpful to get speciﬁc.
What push in chemical self-assembly might be most worth-
while and practical? Self-assembly in vitro of viruses and
the ribosome, achieved decades ago, taught us some of the
principles assumed to be used in general by cells (Lewin,
2004). For example, self-assembly occurs in a deﬁnite
sequence and is generally energetically favored, obviating
the need for enzymes and an energy source. Assembling some
type of cell (i.e. a self-replicating, membrane-encapsulated
collection of biomolecules) would seem to be the next major
step, yet detailed plans have not been published. Here, we
attempt to outline the synthesis of a minimal cell containing
the core cellular replication machinery, review the pertinent
literature and highlight gaps in knowledge that need ﬁlling.
Utility
Synthesizing a minimal cell will advance knowledge of
biological replication. Many hypotheses in replication and its
subsystems can only be tested in such a synthetic biology
project. The meaning of ‘synthetic’ (from Greek sunthesis,t o
put together) discussed here bypasses the current reliance of
syntheticbiologyon cellsor macromolecularcell products: the
aimistoputtogetheranorganismfromsmallmoleculesalone.
The simplest approach for creating an artiﬁcial cell may be
by evolving an RNA polymerase made exclusively of RNA
(Szostak et al, 2001) to replace all protein components of
in vitro replicating and evolving systems (e.g. to replace Qb
replicase; Mills et al, 1967). But in comparison with a puriﬁed
protein-based system, it is neither guaranteed to arrive sooner
nortellusmore.Aprotein-basedsystemwillconnectwith,and
reveal more about, existing biological systems. Life, like a
machine, cannot be understood simply by studying it and its
parts; itmustalsobe put togetherfromits parts.Along theway
to synthesizing a cell, we might discover new biochemical
functions essential for replication, unsuspected macromole-
cular modiﬁcations or previously unrecognized patterns of
coordinated expression.
How good a model would an artiﬁcial, protein-based,
minimal cell be for natural cells? The only cellular alternative
is a perturbed natural cell, an incredibly complex system even
for the simplest of cells.A much simpler puriﬁed system based
on a real cell would thus be easier to model and understand.
It could certainly answer questions that cannot be answered
invivoorincrudeextracts,suchaswhichmacromoleculesand
macromolecular modiﬁcations are sufﬁcient for subsystem
function. However, even the simplest minimal cell would still
be highly complex; so its construction and study would be
facilitated by substituting some of the necessary subsystems
with simpler analogs. Should the simpler in vitro model turn
out to be a poor model for the more complex in vivo system,
one could always construct a more complex in vitro system
that may better reﬂect in vivo.
Synthesizing a cell will also lead to new applications.
Puriﬁed biochemical systems already offer major advantages,
such as the polymerase chain reaction (PCR) and in vitro
transcription. A better understanding and manipulation of all
cellular replication subsystems (molecular biology’s tool kit)
should spin off new technologies. For example, in vitro
genome replication may be useful for replicating very large
segments of DNA with high ﬁdelity. Combined in vitro
transcription, RNA processing and RNA modiﬁcation would
allow preparation of rRNAs and tRNAs with deﬁned modiﬁca-
tions totest the roles ofthe modiﬁcations,andmodiﬁed tRNAs
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Article number: 45to aid incorporation of unnatural amino acids into proteins.
Puriﬁed translation systems have enabled reassignment of
mRNA codons to encode unnatural amino acids by omission
of competing natural amino acids (Forster et al, 2003); further
improvements of the puriﬁed translation system could enable
the genetic selection of protease-resistant, peptide-like ligands
for drug discovery by pure translation display (Forster et al,
2004). The puriﬁed translation system may also facilitate
expression of proteins difﬁcult to express by standard
approaches. Better control of lipid vesicle synthesis could
advance liposome-based drug delivery. Since bacterial transla-
tion is the main target of antibiotics, greater understanding
may assist development of new drugs to ﬁght mounting
antibiotic resistance. Ultimate success in cell synthesis could
generate useful microorganisms, for example, for renewable
production of biodegradable plastics (Pohorille and Deamer,
2002).
Approach
The ideal approach for synthesizing a cell would allow all
of the machine parts to be understood and tested. Like any
engineering project, this requires detailed blueprints, raw
synthetic capabilities and an overall diagnostic and debugging
strategy. The use of entire genomes as the blueprints, some of
which are small enough to synthesize de novo, is inconsistent
with this approach. Self-replication of an unadulterated
genome, however impressive, would not deﬁne the unneces-
sary genes, and the functions of about a third of the genes
would remain unknown (Fraser et al, 1995; Jaffe et al, 2004).
Building a machine from mysterious parts can only create a
mysterious machine. What is needed is somewayof deﬁning a
near-minimal genome and then a strategy that will lead
inexorably to an understanding of all of its parts.
Theoretical and experimental studies have attempted to
establish a minimal set of genes needed for a self-replicating
system in a cushy constant environment of unlimited, small
molecule nutrients. Three basic approaches present them-
selves.
Comparative genomics
Comparative genomics searches for genes that have homologs
in the genomes of groups of organisms. The approach
estimates from 50 to 380 genes in a minimal genome
(Mushegian and Koonin, 1996; Tomita et al, 1999; Koonin,
2000; Jaffe et al, 2004). It has the caveat that, among closely
related genomes, some genes appear ‘required’ for those
species (e.g. many of the genes retained in the synthetic
reduced genome Escherichia coli (Posfai et al, 2006)) although
they are not required for basic life. If one goes to longer
evolutionary distances, many gene functions are replaced by
non-homologous genes, hence making some essential genes
lookdispensable(e.g.someofthetRNAmodiﬁcationenzymes
used by Mycoplasma are either different from E. coli or
unidentiﬁed by sequence identity, but that does not mean the
different ones are dispensable). An additional challenge is that
about a third of the essential genes have unknown functions.
It is thus expected that a minimal genome based on this
approachalonewouldbeinviable,anditwouldnotbepossible
to identify the missing essential genes.
Genetics
Genetics searches for essential genes by mutating one gene
at a time. This approach estimates 430 genes in a minimal
genome (out of Mycoplasma genitalium’s total of 528;
Supplementary Table S3; Hutchison et al, 1999; Glass et al,
2006). About a ﬁfth of these essential genes have unknown
functions. It is limited by false ‘essentials’ due to the fraction
of genes that were never mutated in the screen, due to
creation of toxic partial complexes or pathways, and due to
inadvertent effects on adjacent genes. The latter effects are
prevalent in bacteria because a primary RNA transcript
typically encodes multiple gene products. At the other
extreme, false ‘dispensables’ are disastrous when trying to
assemble a viable minimal genome that lacks all of the
individual ‘dispensables’. For example, most RNA modiﬁca-
tion enzymes are individually dispensable, but simultaneous
deletionoftensofthemwouldbeexpectedtobeunsustainable
due to cumulative reductions in efﬁciency or ﬁdelity (a useful
working deﬁnition of essentials for a minimal genome should
encompass such lethal ‘dispensables’). Again, in using this
approach alone, it would not be possible to identify the
missing essential genes.
Biochemistry
Biochemistry identiﬁes from cell fractions those gene products
essential for the reconstitution of biochemical reactions. It
does not suffer from the above problems (except creation of
toxic partial complexes), gives access to details of kinetic steps
and allows debugging of isolated subsystems. However, the
cellular subsystems must be integrated and thoroughly tested
for accuracy on long templates before they can be considered
physiological. Nevertheless, the biochemical approach has
been successful at identifying macromolecules sufﬁcient for
reconstituting DNA, RNA and protein syntheses and, based
on individual subtraction experiments, the components have
either been shown to be necessary or could be so tested.
Mindful of the remaining self-replication functions that need
to be discovered (see below), it seems likely that a largely
biochemical approach, now further empowered by mass
spectrometry analyses and genetic and comparative genomic
information, will be the most practical route to deﬁne a near-
minimal, well-understood genome. We now review the
relevance of current knowledge and technology to this new
minimal cell project (MCP; Luisi, 2002).
A minimal genome
AnMCPmayberealizedbyreconstitutingthemacromolecular
catalyststhatsynthesizeDNA,RNAandprotein.However,this
overlooks the formation of the membrane compartment and
the poorly understood process in which it is divided by
membrane proteins (Gitai, 2005), both of which are required
for life. But lipids alone have been shown to be sufﬁcient for
formation of rudimentary membranous compartments cap-
able of both transmembrane transport of small molecules and
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proteins may be dispensable. Polysaccharides should also be
dispensable. If the simplest and best-characterized examples
of DNA, RNA and protein synthesis are selected, if translation
of all codons is enabled for generalizability and if efﬁciency
and accuracy are not compromised, then this leads to the
macromolecules and pathways of Figure 1.
A detailed list of the gene products in the hypothetical
synthetic minimal cell of Figure 1 is shown in Table I (left
column). This list overlaps with a computational model of
minimal cell genes largely derived from a minimal organism,
M. genitalium (Tomita et al, 1999; Supplementary Table S4),
but differs by omitting enzymes for synthesizing small
molecules (e.g. lipids and glycolysis substrates) and by
including DNA replication, RNA processing, RNA modiﬁca-
tion, extra tRNAs to decode the whole genetic code, some
additional essential translation components and chaperones.
It should be emphasized that Table I is a working model only
and that strict adherence will likely hamper progress.
Examples of omitted, potentially stimulatory genes are given
below and in Supplementary Table S1. Conversely, examples
of included, potentially dispensable genes may be gleaned by
comparisonwith the streamlined Mycoplasma genome (Fraser
et al, 1995; Table I, middle column; Supplementary Table S2).
Several conclusions can be drawn from the provisional list
of genes selected for a minimal cell, most of which are
attractive when contemplating an MCP. In genomic terms, the
list is very short, containing only 151 genes and 113kbp. All
of the genes are derived from E. coli and its bacteriophages
(except for the hammerhead RNA from a plant virus; Forster
and Symons, 1987), implying that the individual subsystems
will be compatible. In contrast to lists derived by comparative
genomics or genetic approaches, the biochemically based list
does not contain any genes of unknown function or challen-
ging membrane proteins; so it is close to a fully understood,
accurately replicating ‘platform’ for life. The few known gaps
constitute only about seven genes, all of which are predicted
to be for RNA modiﬁcation (Table I, bold in the left column).
From the viewpoint of structural biology, courtesy of recent
breakthroughs in ribosome structure determination (Diaconu
et al, 2005; Ogle and Ramakrishnan, 2005), signiﬁcant three-
dimensional information is lacking for only 3% of the
products: a few RNA modiﬁcation proteins and aminoacyl-
tRNA synthetases (Table I, right column). While some of the
states and complexes remain to be solved at high resolution,
a draft three-dimensional structure for any replicating system
is a major milestone in the history of biology.
Tools
Genes for an MCPcould be synthesized using either natural or
unnatural gene sequences as starting points. Using natural
gene sequences, genes can be readily synthesized by PCR, and
large cloned operons of essential genes can be fused using
synthetic linkers and homologous recombination. However,
gene synthesis by cloning and PCR will soon be more
expensive than raw synthesis from synthetic oligo-
deoxyribonucleotides (oligos). The latter also allows unnatur-
al sequences, such as versions with altered codon bias to
adjust mRNA secondary structures (Tian et al, 2004).
Scalability and cost limitations of established methods for
gene synthesis from synthetic oligos are now being overcome
by oligo synthesis on chips followed by PCR ampliﬁcation
and error correction (Carr et al, 2004; Richmond et al, 2004;
Tian et al, 2004; Zhou et al, 2004).
Biochemical subsystems
Several biochemical subsystems are required to synthesize a
minimal cell, and they are reviewed here. For each subsystem,
possible examples from natural systems will be compared,
gaps in knowledge will be identiﬁed and diagnostic and
debugging strategies to ﬁll the gaps will be suggested. Mindful
ofthegoalofintegrationofthesubsystems,emphasis isplaced
on subsystems that are homologous and that operate under
standard physiological conditions.
Genome replication
In principle, the genetic material for an MCP could be either
DNA or RNA. Although an RNA genome has the advantage
of obviating genes for DNA replication, the challenges of
preventing inhibitory double-stranded RNA structures and
replicative mutations in artiﬁcial RNA genomes (Mills et al,
1967) are unsolved. So the genetic material for an MCP should
be DNA.
Figure 1 A minimal cell containing biological macromolecules and pathways
proposed to be necessary and sufﬁcient for replication from small molecule
nutrients. The macromolecules are all nucleic acid and protein polymers and are
encapsulated within a bilayer lipid vesicle. The small molecules (brown) diffuse
acrossthebilayer.Themacromoleculesareorderedaccordingtothepathwaysin
which they are synthesized and act. They are colored by biochemical subsystem
as follows: blue¼DNA synthesis, red¼RNA synthesis and cleavage, green-
RNA modiﬁcation, purple¼ribosome assembly, orange¼post-translational
modiﬁcation and black¼protein synthesis. MFT¼methionyl-tRNA
fMet
i formyl-
transferase. The system could be bootstrapped with DNA, RNA polymerase,
ribosome, translation factors, tRNAs, MTF, synthetases, chaperones and small
molecules.
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completely integrated with biological systems is shown in
Figure 2. It shows rolling-circle DNA strand displacement
(Zhong et al, 2001) initiated with RNA transcript primers
synthesized in situ by an RNA polymerase. Processing of the
resulting double-stranded DNA concatemers into monomeric
DNA circles occurs by homologous recombination at Lox sites
catalyzed by Cre recombinase (Sauer, 2002). This approach
has advantages over existing rolling-circle (Dahl et al, 2004)
or PCR (Mitra and Church, 1999) replication methods, as it
Table I Biochemically derived list of genes that may encode a useful, near-minimal, self-replicating system dependent only on small molecule nutrients
Escherichia coli Mycoplasma 3D structure
Coliphage f29 DNA polymerase + +
Coliphage P1 Cre recombinase   +
4Coliphage Lox/Cre recombinase site   +
Coliphage T7 RNA polymerase Analog +
4Coliphage T7 RNA polymerase initiation site Analog +
4Coliphage T7 RNA polymerase class II termination site Analog +
Lucerne viral hammerhead RNA   +
RNase P RNA ++
RNase P protein ++
4RNase P site/RNA primer for DNA polymerase + +
Small subunit 16S ribosomal RNA + +
All 21 small subunit ribosomal proteins (1–21) + except 1, 21 +
Large subunit 5S ribosomal RNA + +
Large subunit 23S ribosomal RNA + +
Large subunit 23S rRNA G24454m2G methylase: unidentiﬁed Unknown  
Large subunit 23S rRNA U24494dihydroU synthetase: unidentiﬁed Unknown  
Large subunit 23S rRNA U24574pseudoU synthetase Unknown  
Large subunit 23S rRNA C24984Cm methylase: unidentiﬁed Unknown  
Large subunit 23S rRNA A25034m2A methylase: unidentiﬁed Unknown  
Large subunit 23S rRNA U25044pseudoU synthetase Unknown  
All 33 large subunit ribosomal proteins (1–7, 9–11, 13–25, 27–36) + except 25, 30 +
Translational initiation factor 1 + +
Translational initiation factor 2 + +
Translational initiation factor 3 + +
Translational elongation factor Tu + +
Translational elongation factor Ts + +
Translational elongation factor G + +
Translational release factor 1 + +
Translational release factor 2   +
Translational release factor Gln methylase + +
Translational release factor 3   +
Ribosome recycling factor + +
33/45 tRNAs (see Figure 3) Set of 29 +
tRNA C344lysidine synthetase Unidentiﬁed +
tRNA A344I deaminase Unidentiﬁed +
tRNA U344cmo5U (¼V) synthetases: unidentiﬁed   
tRNA U3442sU Cys desulfurase   +
tRNA U3442sU synthetase Unidentiﬁed +
tRNA U344cmnm5U GTPase Unidentiﬁed +
tRNA U344cmnm5U synthetase Unidentiﬁed +
tRNA cmnm5U344nm5U4mnm5U synthetase Unidentiﬁed  
tRNA G37 N1-methylase + +
tRNA A374t6A N6-threonylcarbamoyl-A synthetase: unidentiﬁed Unidentiﬁed  
tRNA A374i6A synthetase   +
tRNA i6A374s2i6A4ms2i6A synthetase   +
All 22 aminoacyl-tRNA synthetase subunits (20 enzymes) + except Gly sub., Gln + except Gly sub., Ala
Met-tRNA formyltransferase + +
Chaperonin GroEL ++
Chaperonin GroES ++
151 genes¼38 RNAs+113 proteins
Gapsinknowledgeareinbold.Leftcolumn:chosengeneproductsandDNAsites.Middlecolumn:relationshiptotheminimalgenomeofM.genitalium;clearsequence
homolog¼‘+’; known enzyme product without an evident sequence homolog¼‘unidentiﬁed’; no functional homolog¼‘ ’. Right column: high-resolution, three-
dimensional, structuralinformation; 425% of the structure solved¼‘+’, o25%¼‘ ’. The small molecules known to be requiredarefourdNTPs,four NTPs, 20amino
acids, N-5,10-methenyltetrahydrofolate, S-adenosylmethionine and isopentenyl pyrophosphate). Note: a full version listing the nomenclature, database link, length
and sequence of each individual product is available in Supplementary Tables S1 and S2.
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temperature, and is far simpler than natural DNA replication
systems (Khan, 1997).
Rolling-circleDNAstranddisplacementcould beengineered
in a stepwise manner. First, a simpler version could be
constructed in which the T7 RNA polymerase and RNA
processing are substituted by addition of short RNA primers
to test the effect of multiple initiation sites. The efﬁciency of
synthesis of monomeric DNA circles would be followed by gel
electrophoresis (Dahl et al, 2004), and replication ﬁdelity at
the base pair and whole genome levels should be tested with
different polymerases. The biggest challenge anticipated is
boosting the efﬁciency of monomeric circular template
generation over by-products, such as linear DNAs or oligo-
meric circles. Such defective by-products would also be
replicated and compete for nutrients (like PCR deletion
products or defective interfering viruses). Defective by-
products potentially could be weeded out with appropriate
selection schemes. For example, encapsulation of individual
genomes within membranous cells would result in non-
viability of cells containing deleted genomes. However,
encapsulation would raise new challenges, especially for large
genomes.ThismightbeaidedbycompactingtheDNAthrough
addition of DNA gyrase.
Transcription
A single RNA polymerase should sufﬁce for an MCP. E. coli’s
multi-subunit enzyme (Lewin, 2004) or the single polypeptide
enzymeencodedbycoliphageT7(Studieretal,1990)seemsto
be the best, with the choice inﬂuenced by several considera-
tions that also determine possible modes of regulation. In
considering the whole transcription cycle for a minimal
replicating system, the simpler, more predictable T7 RNA
polymerase is arguably a better starting point than the E. coli
RNA polymerase (a detailed comparison is provided in
Supplementary information).
RNA processing
A host of RNases cleave precursor RNAs in vivo (Li and
Deutscher, 1996) with a complexity that could be reproduced
in anMCP. However, inclusion of these RNasescomes with the
risks of cryptic cleavages, and a simpler approach may be
easier to engineer (Figure 2, top). This approach generates all
required unadulterated termini: tRNA 50 and 30 ends (Forster
and Altman, 1990) and, if necessary, the 30 end of an rRNA.
The self-cleaving sequence (Forster and Symons, 1987) is
included because precursor tRNAs with substantial 30 exten-
sions can be poor substrates for RNase P (Li and Deutscher,
1996) and RNA polymerase terminators are inefﬁcient. The
efﬁciency of RNA processing, monitored by gel electrophor-
esis, could be improved by trying several different precursor-
speciﬁc sequences.
A minimal translatome
The most complex universal biological machinery is clearly
translation. Translation-associated genes (the ‘translatome’)
account for a large fraction of cellular genes, 96% of the genes
in Table I, and all of the currently predicted gaps in knowledge
of an MCP. The eukaryotic version is less attractive for
engineering than the bacterial version because it contains
some 30 initiation factor proteins and because eukaryotic
ribosome assembly in vitro awaits the coordination of more
than a hundred non-ribosomal macromolecules (Fromont-
Racine et al, 2003). Of the bacterial systems, Mycoplasma has
advantages over E. coli owing to its eight-fold-smaller minimal
genome and its simple set of 29 tRNAs that is the only
completely characterized set (Andachi et al, 1989). Unfortu-
nately, other important biochemical information for Myco-
plasmaisessentially unknowninareaswhereitiswellstudied
in E. coli (e.g. reconstitution of ribosomes and translation,
characterization and functional assays of rRNA modiﬁcations,
characterization of RNA modiﬁcation enzymes). Presently,
this seems to favor the E. coli translatome for an MCP.
L
L
P
T
tRNA1
rRNA
5′ 
5′ 
5′ 
5′ 
L
tRNA 2 H
Primer
Primer
tRNA  1
rRNA
RNase P
Self-cleavage
RNase P
Figure 2 A generalizable, physiologically compatible, theoretical scheme for
accurate DNA replication and RNA synthesis in vitro. Polymerase movements
are illustrated by colored arrowheads. DNA synthesis: a nicked double-
stranded DNA circle (middle) undergoes rolling-circle DNA synthesis by
coliphage f29 DNA polymerase (Dahl et al, 2004) to give an oligomeric
single-stranded DNA (bottom, blue). RNA primers (red) then hybridize at two
sites to prime lagging strand DNA synthesis (bottom, green). When two Lox sites
(bottom, L) are completed, recombination occurs between them catalyzed by
coliphage P1 Cre recombinase (black cross) to form a duplicate of the original
circular template. RNA synthesis: the circular genetic operon (middle)
contains a promoter for T7 RNA polymerase (P), a ribosomal RNA (rRNA) gene,
two transfer RNA (tRNA) sequences, a self-cleaving hammerhead sequence (H)
and a T7 terminator (T). RNA synthesis from P generates a precursor RNA (top,
red) containing three cleavage sites (thin black arrows). The second tRNA
sequence merely serves as a recognition site for RNase P cleavage. Cleavages
yield the maturerRNAand tRNA1.Anycleavage product containing a30 hydroxyl
group or primary RNA transcript can serve as a primer for DNA synthesis
(bottom, red).
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Efﬁcient synthesis of proteins has been reconstituted from
puriﬁednaturalcomponents(Kungetal,1978)orrecombinant
His-tagged translation factors (Shimizu et al, 2005) from
E. coli, but not yet from eukaryotes. The next steps with the
E. coli system will be verifying accuracy by mass spectrometry
and extending the short lifetime of the batch mode by
continuous dialysis (Spirin et al, 1988). The versatility of the
systemwillbecomeapparentasmoremRNAs aretranslated.If
stronger mRNA secondary structures prove inhibitory despite
the helicase activity of the ribosome (Takyar et al, 2005),
introduction of an RNA helicase may be helpful. Given that
aminoacyl-tRNA synthetases, translation factors and riboso-
malproteinsare among the mostabundant proteinsin the cell,
it will be important to verify that the puriﬁed system can
produce high concentrations of all of these proteins.
An in vitro ribosome
The ribosomeofchoiceis from E.colibecause,in contrast with
its eukaryotic cousins, it has been self-assembled from its
puriﬁed components (Traub and Nomura, 1968; Nomura and
Erdmann, 1970; Nierhaus and Dohme, 1974) and is homo-
logous with the other components of the gene list (Table I).
Reconstituted ribosomes have only been assayed by synthesis
of phenylalanine polymers from polyU templates (Lietzke and
Nierhaus, 1988); so future assays need to test initiation and
elongation at non-UUU codons, and also termination. Further-
more, the self-assembly protocol is ﬁnicky and non-physiolo-
gical. In vitro assembly of the 30S subunit under physiological
temperatures has been attained recently by adding the DnaK/
DnaJ/GrpE chaperone system (Maki and Culver, 2005),
although this system is dispensable in vivo (El Hage et al,
2001). Perhaps addition of natural polyamines might over-
come the requirement for an unphysiologically high concen-
tration of magnesium ions. All 54 of the ribosomal proteins
have been cloned (Culver and Noller, 1999; Semrad et al,
2004); the hypothesis that they (and other proteins in Table I)
can be synthesized in a puriﬁed translation system in active
forms warrants testing.
rRNA production in a puriﬁed system is complicated by
post-transcriptional nucleoside modiﬁcations. Since 5S rRNA
lacks nucleoside modiﬁcations and is short, it is not surprising
that it is active when transcribed in vitro (Zvereva et al, 1998).
But the other two rRNAs are modiﬁed by about 20 enzymes in
E. coli, half of which are unidentiﬁed. All 11 modiﬁcations of
the E. coli small subunit 16S rRNA are dispensable for subunit
assembly and aminoacyl-tRNA binding (Krzyzosiak et al,
1987). However, E. coli 23S rRNA lacking its 23 modiﬁcations
is 30-fold less active than the natural version in N-Ac-Met-
puromycin synthesis (Semrad and Green, 2002) due to one to
six modiﬁcations in a relativelysmall RNAdomain (Greenand
Noller, 1996). The enzymes that catalyze these six modiﬁca-
tionsarethereforeincludedinTableI,althoughthetwoknown
ones are individually dispensable (Del Campo et al, 2001).
Other bacteria should also be entertained for an MCP, as these
six E. coli modiﬁcations are not conserved and the unmodiﬁed
23S RNAs from two other eubacteria are quite active (Green
and Noller, 1999; Khaitovich et al, 1999).
In vitro tRNAs
Which of the myriad tRNA genes and tRNA modiﬁcation
enzymes are likely to be sufﬁcient to decode all 61 sense
codons in an MCP? There are some 85 tRNA genes in E. coli
coding for some 45 different tRNAs each bearing post-
transcriptional modiﬁcations on about 10% of their nucleo-
sides (Supplementary Table S5), and a ﬁfth of the tRNAs still
remaintobecharacterizedatthemodiﬁcationlevel.Atleast27
different types of nucleoside modiﬁcations are present in
E. coli (Bjork, 1995). There are an estimated 40–50 tRNA
modiﬁcation enzymes in E. coli, about half of which remain
to be identiﬁed. To make matters worse (or more interesting)
for an MCP, the roles of the tRNA modiﬁcations are
controversial.
Arguments for choosing essential tRNA modiﬁcation
activities are highly speculative (detailed in Supplementary
information). As few as 33 E. coli tRNAs may be sufﬁcient
to translate the entire genetic code accurately (Table I, left,
and Figure 3). E. coli tRNAs could be substituted with the
completely characterized set from Mycoplasma capricolum
(Supplementary Table S7), which contains only 14 types of
nucleoside modiﬁcations (Andachi et al, 1989), some of which
differ from E. coli (Supplementary Table S1). However, the
predicted savings in the number of essential tRNAs and
modiﬁcationenzymesareminor(TableI,middlecolumn),and
full compatibility with the heterologous E. coli translation
apparatus seems unlikely (e.g. the codon UGA in Mycoplasma
encodes Trp, not stop).
Each in vitro-synthesized nascent tRNA transcript should be
modiﬁedwithdifferentcombinationsofmodiﬁcationenzymes
and tested for efﬁciency and accuracy of codon recognition in
translation, initially in a simpliﬁed puriﬁed translation system
(Forster et al, 2001). Identiﬁcation of the unknown modiﬁca-
tion enzymes is being hastened by bioinformatic and genomic
approaches (Soma et al, 2003). It is also conceivable, although
unlikely, that unknown small molecules would need to be
identiﬁed biochemically for RNA modiﬁcation (or other
reactions). The remaining E. coli tRNA modiﬁcation enzymes
not listed in Table I might be predicted to be dispensable based
onavailabledata(Bjork,1995;Giegeetal,1998).Butgiventhe
uncertainties,itmaybefastertogettoaworkingnear-minimal
cell by using every known E. coli modiﬁcation enzyme. Such a
systemwould be ideallysuited for freeingup codons to encode
unnatural amino acids: this would be carried out by omission
of one or more codons from all mRNAs and omission of their
cognate tRNAs.
Post-translation
An MCP must promote correct protein folding and any
necessary post-translational amino-acid modiﬁcations. Early
versions of a puriﬁed replicating system will contain cell-
derived macromolecules, so establishing that such systems
can be completely weaned from cells will require enough
rounds of replication for ‘inﬁnite’ dilution of the starting
macromolecules. This will test for dependence on folding by
chaperones and on post-translational modiﬁcations. It is
unclear which, if any, chaperones will be necessary, but
GroEL/ES (El Hage et al, 2001; Kerner et al, 2005) are likely
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post-translational modiﬁcations for the proteins in Table I are
the recently discovered methylations of translation release
factors 1 and 2 catalyzed by release factor Gln methylase
(Table I) (Heurgue-Hamard et al, 2002; Nakahigashi et al,
2002). Other possibilities include ribosomal protein acetyla-
tions. Mass spectral comparisons between proteins made in
the puriﬁed system and those made in vivo will expose
modiﬁcations and also assess ﬁdelity, while the inactivity of
a protein of expected mass would suggest a protein-folding
deﬁcit and the need for an additional chaperone. Any
necessary missing components could be identiﬁed biochemi-
cally by mixing with fractionated crude extracts or through
genetics.
Compartments and division
Membranes would allow evolution without serial transfers
and puriﬁcations, extension of the system to new environ-
ments and better modeling of cells. On the other hand,
membranous boundaries are unnecessary for directed evolu-
tion (Mills et al, 1967) or, in theory, self-replication.
Membranes also restrict applications (e.g. deliveryof unnatur-
al amino acyl-tRNAs, selection schemes based on binding and
spacial arraying for nanofabrication). Addition to self-replicat-
ing macromolecules of lipids alone may be sufﬁcient for
encapsulation of the macromolecules within bilayer mem-
brane vesicles, synthetic cell division and transmembranous
small molecule transport (Szostak et al, 2001). The choice of
lipids is wide open, but one should not underestimate the
challengesinvolvedinworkingwiththem(Luisi,2002)northe
advantages in regulation to be gained by adding membrane-
modeling proteins (e.g. pores, transporters and the yet-to-be-
discovered complement of cell division proteins; Gitai, 2005).
Integrating the subsystems
How might all of the biochemical subsystems in Figure 1 be
combined to generate a self-sustaining system? This is clearly
a new level of complexity in comparison with prior self-
assembly projects. None of the subsystems described above
arecompleted,yettheirselectionisbasedonareasonableplan
for their ultimate integration. The approach again would be
stepwise, and there are many possible pathways that could
be integrated in parallel (Figure 1). For example, transcription
by T7 RNA polymerase couples well with a puriﬁed E. coli
translation system (Shimizu et al, 2005). Theoretical integra-
tionofDNAsynthesis,RNAsynthesisandRNAprocessingwas
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could then be combined to synthesize part of a ﬁfth system
(the ribosome) by synthesis of an antibiotic-resistant 16S
rRNA and His-tagged versions of all 21 small subunit
ribosomal proteins (Tian et al, 2004). The products of these
integrated subsystems could then be assayed for correct in
vitroreconstitutionofsmallribosomalsubunitsby(i)selecting
for resistance of protein synthesis to the antibiotic, and (ii)
detecting the presence of tagged proteins in puriﬁed small
ribosomal subunits by Western blot with anti-His antibodies.
As another example, rudimentary vesicles encapsulating
replicating systems (e.g. Qb replicase) were shown to be
capable of multiplication (Luisi, 2002).
Numerous ﬁne-tuning strategies can be envisioned. Relative
strengths of DNA promoters and mRNA ribosome-binding
sites for different genes could be modeled on the in vivo
strengths, with necessary adjustments of synthetic rates (and
thus concentrations of products) achieved by mutations in the
binding sites (see Supplementary information on transcrip-
tion). Additional modules might be useful, such as catabolism
(nucleases and proteases), active conversion or removal of
waste products (e.g. by energy regenerating enzymes (Supple-
mentary Table S1) or membrane transporters) and regulatory
feedback (e.g. excess transcription-excess T7 lysozyme
mRNA-excess lysozyme-lysozyme binding to and inhibi-
tion of T7 RNA polymerase). Control of macromolecular
concentrations will be aided by in silico modeling and design
(Tomita et al, 1999). Given that the subsystems discussed
above were selected with integration in mind by choosing
physiological reaction conditions and homologous compo-
nents, and given that additional subsystems could always
be borrowed from living cells as needed (e.g. E. coli RNA
polymerase (Supplementary TableS1)and regulatory modules
such as riboswitches (Isaacs et al, 2004)), it seems likely that
this approach will eventually produce synthetic self-replica-
tion and ultimately a self-sustaining minimal cell.
It is important to note that a minimal cell would be
intentionally fragile. For example, the vesicle would
be easily lysed and the small molecule feeding mix would be
highly specialized indeed (including unstable cofactors such
as N-5,10-methenyltetrahydrofolate and S-adenosylmethio-
nine). These built-in safety features will prevent a minimal
cell from replicating outside the laboratory. However, some or
all of the synthetic genes for an MCP would be intentionally
passaged through living cells for construction of recombinant
DNAclonesandforampliﬁcation.Constantlyupgradedethical
and safety regulations in place for existing biohazards
would also encompass this research (Cho et al, 1999; http://
arep.med.harvard.edu/SBP/Church_Biohazard04c.htm).
Completion
In conclusion, a stepwise biochemical approach lends itself
to the eventual identiﬁcation of any remaining functions
essential for the synthesis of a minimal cell sustained solely by
small molecules. Five states of completion present themselves
as tractable goals of an MCP. Namely, the identiﬁcation of
(1) the genes listed as missing in Table I,
(2) any additional genes and organization necessary experi-
mentally for minimal cell synthesis,
(3) any dispensable genes,
(4) biochemical parameters and computational models sufﬁ-
ciently detailed to predict the effects of alterations and
(5) the missing three-dimensional structures of the gene
products and their relevant complexes.
It is difﬁcult to predict how long it will take to debug each
of the individual biochemical subsystems or to put them
all together; so it is important to bear in mind that there are
short-term goals (see the Utility section). Intermediate
assembly steps could also be pursued while the gaps in RNA
modiﬁcationknowledge(TableI)arebeingﬁlled.Forexample,
the project to assemble a ribosome under physiological
conditions could be carried out without the missing 23S
rRNA modiﬁcation enzymes (Table I) by substituting in
natural 23S rRNA. Similarly, assembly of self-replication in
the absence of functional in vitro-synthesized tRNA substrates
could be carried out using cellular total tRNA to enable
self-replication from substrates (rather than just small
molecules) as a major step towards understanding biological
self-replication. This would also allow directed evolution
of all of the components except the tRNAs in a more ﬂexible
manner than is possible in vivo (e.g. for selecting ribosome
mutants that incorporate unnatural amino acids more
efﬁciently).
The biochemical subsystems necessary for an MCP are
central, old ﬁelds that have lost impetus. Completion within a
decade will only be possible through a coordinated ﬁlling of
the key gaps in knowledge by the cutting-edge laboratories
scattered around the world in these ﬁelds. It will also require
stimulation of rate-limiting ﬁelds. For example, although
rRNAs and tRNAs can constitute more than 70% of the dry
weight of a cell, half of the estimated 60–70 RNA modiﬁcation
enzymes of E. coli and one-ﬁfth of the tRNAs remain to be
characterized (Supplementary Tables S5 and S6), despite
the recent completion of about 300 bacterial whole genome
sequences. The momentum of genomics and consequent
deluge of computed hypotheses cries out for comparable
breakthroughs in experimental tests. Synthetic systems
biology projects such as an MCP promise such tests with the
added bonus of new applications.
Supplementary information
Supplementary information is available at Molecular Systems Biology
website (www.nature.com/msb) and at http://arep.med.harvard.
edu/SBP
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